Allspring Global Investments Holdings LLC Acquires 2,274 Shares of UiPath Inc. (NYSE:PATH)

Allspring Global Investments Holdings LLC boosted its holdings in UiPath Inc. (NYSE:PATH) by 124.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,098 shares of the healthcare company’s stock after acquiring an additional 2,274 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in UiPath were worth $52,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. ORG Partners LLC lifted its holdings in shares of UiPath by 875.6% during the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after buying an additional 1,112 shares during the period. Future Financial Wealth Managment LLC bought a new position in shares of UiPath during the 3rd quarter valued at $26,000. JTC Employer Solutions Trustee Ltd bought a new position in shares of UiPath during the 3rd quarter valued at $26,000. Hantz Financial Services Inc. bought a new position in shares of UiPath during the 2nd quarter valued at $28,000. Finally, Advisors Asset Management Inc. lifted its holdings in shares of UiPath by 35.0% during the 1st quarter. Advisors Asset Management Inc. now owns 3,037 shares of the healthcare company’s stock valued at $69,000 after buying an additional 787 shares during the period. 62.50% of the stock is owned by institutional investors.

Analysts Set New Price Targets

PATH has been the subject of several analyst reports. TD Cowen reduced their price objective on UiPath from $17.00 to $16.00 and set a “hold” rating for the company in a research note on Friday, September 6th. Wells Fargo & Company cut their price target on UiPath from $15.00 to $13.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 23rd. JPMorgan Chase & Co. cut their price target on UiPath from $19.00 to $17.00 and set an “overweight” rating for the company in a research note on Wednesday, October 23rd. Royal Bank of Canada reissued a “sector perform” rating and set a $16.00 price objective on shares of UiPath in a report on Friday, September 6th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a report on Wednesday, October 23rd. Sixteen equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $17.47.

UiPath Trading Down 2.0 %

NYSE:PATH opened at $12.32 on Tuesday. UiPath Inc. has a 12 month low of $10.37 and a 12 month high of $27.87. The firm has a fifty day simple moving average of $12.53 and a 200-day simple moving average of $13.73. The company has a market capitalization of $6.78 billion, a P/E ratio of -61.60 and a beta of 0.87.

UiPath (NYSE:PATH) last posted its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.03 by $0.01. The business had revenue of $316.00 million during the quarter, compared to the consensus estimate of $303.69 million. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.09) earnings per share. Equities analysts forecast that UiPath Inc. will post -0.23 EPS for the current year.

Insider Activity at UiPath

In other UiPath news, CFO Ashim Gupta sold 47,671 shares of UiPath stock in a transaction on Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the transaction, the chief financial officer now owns 849,917 shares of the company’s stock, valued at approximately $10,258,498.19. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 22.37% of the stock is currently owned by insiders.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.